The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis-Reference-Cited by-同舟云学术

The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis

Published:2016-09 Issue:5 Volume:82 Page:522-528
ISSN:1808-8694
Container-title:Brazilian Journal of Otorhinolaryngology
language:en
Short-container-title:Brazilian Journal of Otorhinolaryngology

Author:

Dualibi Ana Paula Fiuza Funicello,Martins Ana Maria,Moreira Gustavo Antônio,de Azevedo Marisa Frasson,Fujita Reginaldo Raimundo,Pignatari Shirley Shizue Nagata

Publisher

Elsevier BV

Subject

Otorhinolaryngology

Reference36 articles.

1. The mucopolysaccharidoses;Neufeld,2001

2. The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I;Wraith;Expert Opin Pharmacother,2005

3. Mucopolissacaridoses: Manual de Orientações;Martins,2003

4. The MPS I Registry: design, methodology and early findings of a global disease registry for monitoring patients with mucopolysaccharidosis type I;Pastores;Mol Genet Metabol,2007

5. Laronidase treatment of mucopolysaccharidosis I;Wraith;Biodrugs,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of the peripheral and central auditory pathways in patients with mucopolysaccharidosis;Journal of Communication Disorders;2024-01

2. Hearing Impairment in Mucopolysaccharidosis: A Systems Biology Approach;Journal of Inborn Errors of Metabolism and Screening;2022

3. Hearing loss in inherited metabolic disorders: A systematic review;Metabolism;2021-09

4. Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement;Biomolecules;2021-01-29

5. Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies;BioMed Research International;2020-12-04